India Generic Drugs Market Size Is Booming Worldwide |Fresenius Kabi, Aurobindo Pharma, Sun Pharma

India generic drugs market is being driven by several factors, including the expanding pharmaceutical industry of India, implementation of favorable initiatives from the government, increasing foreign investment, and rising healthcare expenditure in the country

A study, recently conducted by the strategic consulting and market research firm Report Ocean, revealed that India generic drugs market is projected to grow at a CAGR of 11.3% during the forecast period (2022-2028). India generic drugs market is being driven by several factors, including the thriving pharmaceutical industry of India, increasing government initiatives, increasing foreign investment, and rising healthcare expenditures in the country. Moreover, the growing number of health issues and rising health awareness have also created a growing demand for generic drugs in India.

Download Free Sample of This Strategic Report: https://reportocean.com/industry-verticals/sample-request?report_id=MR436

Favorable government initiatives driving the growth of India generic drugs market

Support from the government is essential for the growth of any market in any country. Currently, the Indian government is promoting its "Make in India" policy and encouraging investment in the pharmaceutical industry to make India a global hub and leader in the sector. For instance, the government has launched Production Linked Incentive (PLI) Scheme with a scheme outlay worth USD 2.9 billion. Several other schemes, such as Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS), Pharmaceutical Promotion & Development Scheme (PPDS), and others are also playing a key role in powering India generic drugs market. Additionally, the government allows 100% foreign investment in the pharmaceutical industry, which has helped the country in attracting significant foreign investment. Hence, several initiatives from the government are supporting the growth of India generic drugs market.

Injectable route of administration to register higher CAGR in India Generic Drugs Market

Based on the route of administration, India generic drugs market is bifurcated into topical, oral, injectable, and others. During the forecast period, the injectable segment is expected to register the highest growth rate owing to the quick action of injectable drugs and their minimal side effects. Oral and topical drugs require time to work and may cause side effects. In addition, injectable drugs are preferred for severe diseases and health conditions, contributing to the segment's high growth rate.

Request To Download Sample of This Strategic Report:- https://reportocean.com/industry-verticals/sample-request?report_id=MR436

Impact of COVID-19

There was an explosion in demand for generic medicines in India in 2020 and 2021 as the COVID-19 pandemic swept the country and the world. According to the Ministry of Commerce and Industry, Drug formulations & Biologicals registered an 11.27% increase in FY 2019-2020 from the year before. In FY2022-21, pharmaceutical exports rose 18.07% and reached USD 24.44 billion as per the Pharmaceuticals Export Promotion Council of India (Pharmexcil). Amid the recent emergence of the Omicron variant of the coronavirus, the demand for generic drugs has gone up once again with Dolo 650 and Dolo 500 registering exponential demand. The generic drug market in India is expected to grow strongly in the coming years due to government support and growing demand from both domestic and international markets.

The Leading Players in India Generic Drugs Market are Teva Pharmaceutical Industries, Wockhardt Pharmaceutical, and Sandoz - A Novartis division. Other major players in India generic drugs market are Fresenius Kabi, Aurobindo Pharma, Sun Pharma, Dr.Reddys Laboratories, Lupin, Cipla, and Viatris.

Market Segment:
By Product Type (Simple Generics, Super Generics, And Biosimilars)
By Route Of Administration (Oral, Topical, Injectable, And Others)
By Application (Cardiovascular Products, Anti-Infective Drugs, Central Nervous System Drugs, Anti-Cancer Drugs, Respiratory Products, And Others)
By Distribution Channel (Hospitals/Clinics, Retail Pharmacies, And Online Pharmacies)

India's generic drugs market is a fragmented market with several major players operating within it. The new companies are battling with established players to gain a significant share of the market. Collaboration, merger & acquisitions, partnerships, and launch of new projects are some of the strategies adopted by the players operating in India generic drugs market to gain an advantage over their competitors.

Request To Download Sample of This Strategic Report:- https://reportocean.com/industry-verticals/sample-request?report_id=MR436

Recent Development

In December 2021, Sun Pharmaceuticals announced that it is planning to set up a new manufacturing facility in Andhra Pradesh. Founder of the company, Dilip Shanghvi met Chief Minister of Andra Pradesh YS Jagan Mohan Reddy to discuss the set-up of the plant. Sun Pharmaceuticals is the fourth largest specialty generic pharmaceutical company in the world with global revenues of over USD 4.5 billion. Additionally, it is supported by more than 40 manufacturing facilities. The company supplies its drugs to more than 100 countries around the globe.

In October 2021, AbbVie, the U.S. drug manufacturer which sells the world's top selling drug, Humira, announced that it is planning to launch products in India by the end of 2023 or 2024 from its global portfolio. The company is looking to tap the potential of Indian market for unmet medical needs against diseases such as leukaemia, psoriasis, eczema and Alzheimer's. The company is also considering making India part of its phase-3 trials for potential therapies under development.

Table of Content:

Report Overview
Global Growth Trends
Competition Landscape by Key Players
Data Segments
North America Market Analysis
Europe Market Analysis
Asia-Pacific Market Analysis
Latin America Market Analysis
Middle East & Africa Market Analysis
Key Players Profiles Market Analysis
Analysts Viewpoints/Conclusions
Appendix

Key Reasons to Buy this Report:

Access to date data compiled by means of our researchers. These grant you with historic and forecast data, which is analyzed to inform you why your market is set to change
This allows you to expect market adjustments to continue to be in advance of your competitors
You will be in a position to replica information from the Excel spreadsheet straight into your advertising plans, commercial enterprise presentations, or different strategic documents
The concise analysis, clear graph, and desk structure will allow you to pinpoint the records you require quickly
Provision of market cost (USD Billion) records for every phase and sub-segment
Indicates the area and section that is predicted to witness the quickest increase as nicely as to dominate the market
Analysis through geography highlighting the consumption of the product/service in the area as nicely as indicating the elements that are affecting the market inside every region
Competitive panorama which contains the market rating of the predominant players, alongside with new service/product launches, partnerships, commercial enterprise expansions, and acquisitions in the previous 5 years of organizations profiled
Extensive business enterprise profiles comprising of business enterprise overview, employer insights, product benchmarking, and SWOT evaluation for the primary market players
The cutting-edge as nicely as the future market outlook of the enterprise regarding current traits which contain boom possibilities and drivers as properly as challenges and restraints of each rising as nicely as developed regions
Includes in-depth evaluation of the market from quite a number views via Porter's 5 forces analysis
Provides perception into the market via Value Chain
Market dynamics scenario, alongside with boom possibilities of the market in the years to come, 6-month post-sales analyst help

Request full Report : https://reportocean.com/industry-verticals/sample-request?report_id=MR436

About Report Ocean:

We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today's competitive environment. Report Ocean is a 'one-stop solution' for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:
Report Ocean:
Email: sales@reportocean.com
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 - UNITED STATES
Tel:+1 888 212 3539 (US - TOLL FREE)
Website: https://www.reportocean.com

This release was published on openPR.